WuXi Biologics, a Hong Kong-listed global open-access biologics technology platform company, is to invest €325 million and create 400 new jobs over five years in a new biologics drug substance manufacturing facility on the IDA greenfield site in Mullagharlin in Dundalk, Co. Louth.
This state-of-the-art facility-of-the-future will be built upon the novel approach WuXi Biologics has pioneered deploying multiple single-use bioreactors for commercial biomanufacturing and is also designed to be able to run continuous bioprocessing, a next generation manufacturing technology to be first implemented globally in this campus. A total of 48,000L fed-batch and 6,000L perfusion bioreactor capacity will be installed, representing the world’s largest facility using single-use bioreactors.
The manufacturing project in a 26-hectare campus, the company’s first site outside of China. Around 700 construction jobs will also be created over the course of the building of the plant.
Speaking at today’s announcement in Dundalk, An Taoiseach Leo Varadkar, Prime Minister of Ireland said: “This is the start of something special. We will see the Factory of the Future, right here in Dundalk. It’s the first sizable Greenfield project from China in the pharma sector and I am delighted to see it located here in Dundalk. It’s also the latest in a number of investments in this town which has become a hub for a range of sectors, mainly in the new knowledge based and pharmaceutical sectors.
Louth hosts National Pen, PayPal, Xerox, Wasdell and Prometric, to name just a few. In 2017 there were 24 IDA-supported companies in the county, and the number of jobs created by them has tripled from 1,300 in 2010 to almost 4,000. It’s all part of the Government’s goal to increase regional investment and associated jobs by up to 40 per cent.”